West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,600 | 35,900 | 6,700 | 44,400 | 16,400 |
| Depreciation Amortization | 30,200 | 30,800 | 32,300 | 31,900 | 30,700 |
| Income taxes - deferred | 4,200 | 8,200 | N/A | N/A | N/A |
| Accounts receivable | 2,600 | -9,600 | N/A | N/A | N/A |
| Other Working Capital | 3,200 | -10,700 | -1,800 | 2,800 | 1,300 |
| Other Operating Activity | 5,500 | 1,200 | 33,800 | -11,400 | 15,000 |
| Operating Cash Flow | $47,300 | $55,800 | $71,000 | $67,700 | $63,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47,700 | -39,300 | -41,800 | -34,400 | -24,500 |
| Net Acquisitions | -3,400 | -17,200 | -34,900 | 0 | -1,600 |
| Other Investing Activity | 200 | 1,700 | 2,900 | 1,400 | 1,600 |
| Investing Cash Flow | $-50,900 | $-54,800 | $-73,800 | $-33,000 | $-24,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -23,500 | -16,800 | N/A | N/A | N/A |
| Debt Issued | N/A | 100,000 | N/A | N/A | N/A |
| Debt Repayment | 53,800 | -49,000 | N/A | N/A | N/A |
| Common Stock Issued | 1,500 | 2,800 | N/A | N/A | N/A |
| Common Stock Repurchased | -10,800 | -18,100 | N/A | N/A | N/A |
| Dividend Paid | -9,800 | -10,300 | -9,400 | -9,400 | -8,700 |
| Other Financing Activity | 0 | 0 | -9,600 | 2,300 | -20,200 |
| Financing Cash Flow | $11,200 | $8,600 | $-19,000 | $-7,100 | $-28,900 |
| Exchange Rate Effect | -1,900 | -2,300 | 800 | -2,600 | -100 |
| Beginning Cash Position | 45,300 | 31,300 | 52,300 | 27,300 | 17,400 |
| End Cash Position | 42,700 | 45,300 | 31,300 | 52,300 | 27,300 |
| Net Cash Flow | $-2,600 | $14,000 | $-21,000 | $25,000 | $9,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 47,300 | 55,800 | 71,000 | 67,700 | 63,400 |
| Capital Expenditure | -47,700 | -39,300 | N/A | N/A | N/A |
| Free Cash Flow | -400 | 16,500 | 71,000 | 67,700 | 63,400 |